This PedsCases Note provides a one-page infographic on Tics and Tic Disorders. It was created by Julia Dyck (Pediatric Neurology Resident, University of Alberta) with the help of Dr. Colin Wilbur (Pediatric Neurologist, University of Alberta). 

Click on the image below for the full-screen PDF handout.

Related Content

• Podcast: Pediatric Obsessive-Compulsive Disorder
• Podcast: Approach to Tic Disorders

References

1. Black, K.J., Kim, S., Yang, N.Y. et al. Course of Tic Disorders Over the Lifespan. Curr Dev Disord Rep 8, 121–132 (2021). https://doi.org/10.1007/s40474-021-00231-3

2. Ganos, C., Martino, D., & Pringsheim, T. (2017). Tics in the Pediatric Population: Pragmatic Management. Movement disorders clinical practice, 4(2), 160–172. https://doi.org/10.1002/mdc3.12428

3. Pringsheim, T., Doja, A., Gorman, D., McKinlay, D., Day, L., Billinghurst, L., Carroll, A., Dion, Y., Luscombe, S., Steeves, T., & Sandor, P. (2012). Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Canadian journal of psychiatry. Revue canadienne de psychiatrie,57(3), 133–143. https://doi.org/10.1177/070674371205700302

4. Pringsheim, T., Okun, M. S., Müller-Vahl, K., Martino, D., Jankovic, J., Cavanna, A. E., Woods, D. W., Robinson, M., Jarvie, E., Roessner, V., Oskoui, M., Holler-Managan, Y., & Piacentini, J. (2019). Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology, 92(19), 896–906. https://doi.org/10.1212/WNL.0000000000007466

An author of this Note has received consulting fees from Alexion Pharmaceuticals, unrelated to the topic of submission.